Overview
Status
Active
Registry date
2018-09-07
Share capital
30,000.00 PLN
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 376 days for 2022).
- 2025not filed
- 202407/10/2025
- 202316/07/2024
- 202225/07/2024
- 202108/07/2022
- 202015/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Sector · Wholesale and retail trade; repair of motor vehicles including motorcycles36,019 / 42,241
Top 85%
Voivodeship · Mazowieckie107,844 / 142,033
Top 76%
Country · Poland385,591 / 495,860
Top 78%
Results vs industry
Revenue
This companyUSD 19.34kMedianUSD 1.07mAverageUSD 22.38m
Net profit
This companyUSD -117.17kMedianUSD 37.89kAverageUSD 879.28k
Operating costs
This companyUSD 73.64kMedianUSD 929.75kAverageUSD 21.06m
Assets
This companyUSD 2.26mMedianUSD 609.81kAverageUSD 11.84m
Industry
Public procurement
6 tenders recorded as contractor, with a total value of $256,005.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 28, 2022 | Purchase and delivery of reagents for histopathological tests and filter pipette tips for Zakład Patologii Nowotworów | $43,368$43,368 | Wielkopolskie Centrum Onkologii Im. Marii Skłodowskiej-Curie | |
| Sep 5, 2022 | Supply of materials for the Microbiology Laboratory for the ongoing operations of spwzoz w Stargardzie, divided into 17 lots | $5,186$5,186 | Samodzielny Publiczny Wielospecjalistyczny Zakład Opieki Zdrowotnej w Stargardzie | |
| May 12, 2022 | Supply of consumable laboratory equipment (13) | $17,931$17,931 | Samodzielny Publiczny Zakład Opieki Zdrowotnej Uniwersytecki Szpital Kliniczny Nr 2 Uniwersytetu Medycznego w Łodzi |
Authorized Representatives
Kacper Maciej Matuszyk – Management Board Member
Krzysztof Kanowski – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Krzysztof Kanowskiage 43 | 300 | $4,051.86 | 50% |
Kacper Maciej Matuszykage 35 | 300 | $4,051.86 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2018-11-24.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Vorwarts Pharmasp. z o.o. | $210,138.62 | vorwartspharma.pl | ||
| Black & Whitesp. z o.o. | $154,866.36 | polonus.pl | ||
| Osteoprofsp. z o.o. | $72,065.80 | osteoprof.pl | ||
| THC PharmaS.A. | $39,093.70 | thc-pharma.pl | ||
| EDGE Pharmasp. z o.o. | $19,855.64 | edgepharma.eu | ||
| Arcade Internationalsp. z o.o. | $17,817.26 | arcade-int.pl | ||
| Filicosp. z o.o. | $11,710.75 | filico.eu | ||
| Get Ready Wheelchairssp. z o.o. | $9,842.54 | getreadywheelchairs.com | ||
| Jacek Waksmundzki Trust 2S.K.A. | $5,769.53 | trust.pl | ||
| Optimedussp. z o.o. | $1.00 | optimedus.pl |
Change history
| Date | Event | |
|---|---|---|
| 2022-06-23 | Address change (Ul. Tużycka 8/6, 03-683, Warszawa → Al. Aleje Jerozolimskie 92, 00-807, Warszawa) | |
| 2021-01-27 | PKD change (Removed: 6 codes; Added: 6 codes) | |
| 2020-09-08 | Address change (Ul. Karminowa 4, 03-599, Warszawa → Ul. Tużycka 8/6, 03-683, Warszawa) | |
| 2020-09-08 | Share capital increase (5,000.00 PLN → 30,000.00 PLN) | |
| 2020-09-08 | Name change (Adwiser → Sbd Group) |
FAQ
The main business activity of SBD Group focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on September 7, 2018.
The headquarters is located at: Al. Aleje Jerozolimskie 92, 00-807 Warszawa.
The management board consists of: Kacper Maciej Matuszyk (Member of the Management Board) and Krzysztof Kanowski (Member of the Management Board).
The share capital of the company is PLN 30,000 (approx. $8,104).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $19,335 in 2024, which is a decrease of 96.0% compared to 2023.
No, the company recorded a net loss of $117,173 in 2024. For comparison, in 2023 the loss was $449,791, meaning the company reduced its loss by 75.3%.
The largest operating cost category falls under depreciation and amortization. This category amounted to $42,388 in 2024, representing 58% of all operating expenses.
Last updated: 2026-04-08
